好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Cognition predicted by brain biomarkers and demographic factors
Aging, Dementia, and Behavioral Neurology
P5 - Poster Session 5 (5:30 PM-6:30 PM)
9-019

We set out to carefully map the combined and unique contributions by different modalities for different cognitive outcomes and age ranges in rigorous out-of-sample prediction surveys.

Brain-structural variables and demographics have been demonstrated to be associated with cognitive function across the adult lifespan.

We studied 210 participants (20-79 years old). Data from structural T1, diffusion tensor imaging, FLAIR, and resting state functional MRI scans combined with a neuropsychological evaluation were used. Z-scores for four cognitive domains measuring memory, fluid reasoning, speed of processing, language, and general cognition were computed.  Brain volumes, thicknesses, fractional anisotropy tracts, functional connectivity, white-matter hyperintensity, age, educational and occupational level were used as the predictors, while cognitive performance served as the to-be-predicted outcome in linear multivariate regression models. We initially performed Principal Components Analysis (PCA) to capture the major sources of variance in each modality. By splitting the sample into training and test data sets, a PCA/Subprofile Scaling Model was then used for deriving a model from Principal-Component scores to fit cognitive performance in the training data set, with a subsequent prediction of cognitive performance based on derived model in the held-out test set. Analyses performed in the total sample, and in two age groups (young, old).  

An optimal set of brain biomarkers, and demographics can predict cognition in cognitively normal adults, to various degrees for different cognitive outcomes. For the majority of our analyses, combining the predictions of all brain biomarkers into a “vote” results in a superior outcome, hinting at unique contributions of each brain biomarker modality.

This could be the less invasive and better diagnostic tool of a possible upcoming cognitive decline or neurodegeneration, and –conceivably- a useful tool for a better maintenance of cognition. Our study leads a new way of investigating brain function and could have implications for promoting healthy aging.

Authors/Disclosures
Angeliki Tsapanou, PhD (Columbia University)
PRESENTER
Dr. Tsapanou has nothing to disclose.
No disclosure on file
Yaakov Stern, PhD (Columbia University Medical Center) Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Stern has received intellectual property interests from a discovery or technology relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.